XRTX·98420Q306·US·equity·Healthcare - Biotechnology-13D/G
XRTX (XORTX THERAPEUTICS INC) is held by 1 institutional investors as of Q1 2026. Largest holders: TD Waterhouse Canada Inc. ($19). Net institutional sentiment: Mixed.
See how XRTX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer